
Sign up to save your podcasts
Or


In this week's podcast we chat with Peter Crock, CEO & Chair of Cann Group & MCIA about the Cannabis and "Big Pharma," GMP and changing regulations, Cannabis companies and their interface with the regulator, Cann's future product focus, Genomic sequencing and Accelerated cannabis breeding.
Cann Group:
https://www.canngrouplimited.com/
MCIA:
https://mcia.org.au/
Alt Med:
https://altmed.com.au/
Support the show
By Andrew Dowling and Mitch Kurz4.5
22 ratings
In this week's podcast we chat with Peter Crock, CEO & Chair of Cann Group & MCIA about the Cannabis and "Big Pharma," GMP and changing regulations, Cannabis companies and their interface with the regulator, Cann's future product focus, Genomic sequencing and Accelerated cannabis breeding.
Cann Group:
https://www.canngrouplimited.com/
MCIA:
https://mcia.org.au/
Alt Med:
https://altmed.com.au/
Support the show